91 programming-language-"FEMTO-ST"-"FEMTO-ST" Postdoctoral positions at University of Oxford
Sort by
Refine Your Search
-
-of-the-art laboratory and clinical facilities that form an ideal environment for our translational research agenda. The main objectives of our research programme are to: • Understand the mechanisms
-
on evaluating the abilities of large language models (LLMs) of replicating results from the arXiv.org repository across computational sciences and engineering. You should have a PhD/DPhil (or be near completion
-
junior co-workers. Excellent oral and written communication skills, including proven ability to write in English at a suitable standard What We Offer As an employer, we genuinely care about our employees
-
contributory pension scheme 38 days annual leave A comprehensive range of childcare services Family leave schemes Cycle and electric car loan schemes Employee Assistance Programme Membership to a variety of
-
to the 4th February 2026. You will be investigating the safety and security implications of large language model (LLM) agents, particularly those capable of interacting with operating systems and external APIs
-
. The post-holder will be one of six centre-funded postdoctoral researchers delivering on projects that form our core research programme. They will be a cornerstone of the centre, collaborating across our
-
the universities of Manchester and Oxford. The post-holder will be one of six centre-funded postdoctoral researchers delivering on projects that form our core research programme. They will be a cornerstone of the
-
-workers. Excellent oral and written communication skills, including proven ability to write in English at a suitable standard You will experience of flow cytometry and experience with tissue culture
-
About the role We have an exciting opportunity to join the Wood Lab in the Department of Paediatrics as our Postdoctoral Researcher This role is part of a larger interdisciplinary program focused
-
Baker). The subject of the research project within the Division of Cardiovascular Medicine, University of Oxford is to re-programme immune cells as part of a larger programme to develop novel therapeutics